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We have isolated Recombinant 7 (R7), a spontaneous mutant of SV7, a molecular clone of MoMuSV124. Like SV7, R7
induces subcutaneous fibrosarcomas, spleen tumors, and mesentery tumors infiltrated by proliferating vessels lined by
transformed endothelial cells. However, it also induces brain lesions. We have molecularly cloned and sequenced the R7
proviral DNA and shown that the R7 genome consists of 3401 bp. It has three direct repeats in each enhancer. Its coding
sequence consists of only 176 bp of p15, 263 bp of p30, a 7-bp insertion, and 853 bp of an N-terminally truncated mos
gene. From the sequence of R7 we have deduced that the truncated mos sequence is in-frame with all of the gag sequence
and the 7-bp insertion. The incorporation of the 3* end of the p15 sequence further suggests that the R7 Gag-Mos is
myristylated. We have also shown that the molecularly cloned R7 virus transformed NIH/3T3 fibroblasts about sevenfold
better than the parental SV7. We have also confirmed that molecularly cloned R7 induces the same disease phenotype as
that induced by the nonmolecularly cloned R7. q 1997 Academic Press
In 1973, Ball and co-workers infected mouse thymus – Among the transformed NIH/3T3 cells infected with
virus released by the transformed psi2 cells (Mann et al.,bone marrow (TB) cells with a MoMuSV stock obtained
1983) that were transfected with the SV7 proviral DNAfrom Dr. J. B. Moloney (Ball et al., 1973). After several in
(Yuen et al., 1991), a cell line with a mos integrant ofvitro passages in TB cells, a cell clone (124) and its
approximately 3.4 kb instead of the expected 5.8 kb ofsubclone (349) were isolated. These cell clones were
the parent SV7 viral genome was obtained (Fig. 1). Sinceunusual because they produce a high ratio of MoMuSV to
the 3.4-kb genome was derived from the transfection ofMoloney murine leukemia virus (MoMuLV). The sarcoma
SV7 proviral DNA, we named it Recombinant 7 (R7).virus from clone 124 cells, MoMuSV124, has since been
Like SV7, R7 induces fibrosarcomas infiltrated by pro-molecularly cloned and sequenced (Reddy et al., 1981;
liferating vessels lined by transformed endothelial cellsVan Beveren et al., 1981). We investigated the biology
in subcutaneous tissues, spleens, and mesentery. How-and pathology induced by MoMuSV 349 produced by
ever, this mutant also induces brain lesions (Yuen andclone 349 cells (Yuen et al., 1984; Soong et al., 1984;
Kwak, 1997, manuscript submitted for publication). Thus,Stoica et al., 1990). The sarcomas induced by virus pro-
R7 has a greater disease potential than SV7. Since weduced by cell clone 349 resemble Kaposi’s sarcoma (Sto-
and others previously showed that differences in the ge-ica et al., 1990). To further characterize the genetics of
netics of the mos-containing viruses dictate their patho-the sarcoma virus or viruses produced by 349 cells, the
genicity (Stocking et al., 1986; Yuen et al., 1991), it ismos-containing proviral DNAs were molecularly cloned
likely that R7’s ability to induce brain lesions is caused(Yuen et al., 1991). One of the molecular clones was
by differences between the SV7 and the R7 genomes.designated SV7 (sarcoma virus 7). Restriction analysis
To further characterize the R7 genome, the uninte-(Yuen et al., 1991) and recent sequence analysis of the
grated R7 genomic DNA was isolated as previously de-SV7 genome (unpublished data) showed that its genome
scribed (Yuen et al., 1985). Digestion of the R7 proviralis identical to that of MoMuSV124 (Van Beveren et al.,
DNA with XhoI, ClaI, SacI, SmaI, and HindIII indicated a1981). SV7 is therefore a molecular clone of MoMuSV
unique SacI site in each LTR (data not shown). The SacI–124. We have also shown that SV7 induces fibrosarco-
SacI R7 fragment was inserted into bacteriophage vectormas that are well supplied by vessels in which the endo-
ZAP II (Stratagene) and packaged using Gigapack II XLthelial cells are also transformed (Yuen et al., 1991).
packaging extract (Stratagene) according to the manu-
facturer’s recommendations. The molecularly cloned R7
was subcloned into pBluescript SK(0) and designated1 To whom correspondence and reprint requests should be ad-
dressed. pR7.1. Restriction with additional restriction enzymes
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virus, clone R7N8 cells were superinfected with Mo-
MuLV-TB (Yuen et al., 1985; Yuen and Szurek, 1989). The
MoMuLV-TB genome differs from the standard MoMuLV
genome (Szurek et al., 1988; Yuen and Szurek, 1989). It
is also less virulent than MoMuLV, inducing T-cell
lymphomas at 4 to 9 months postinoculation (Yuen and
Szurek, 1989). The average infectivity (infectious unit/106
cells/ml) as determined by the NIH/3T3 focus-forming
assay (Wong et al., 1981) of the molecularly cloned R7
virus in eight R7-MoMuLV-TB-infected NIH/3T3 cell lines
was found to be about seven times greater than the
average infectivity of SV7 virus in six SV7-MoMuLV-TB-
infected NIH/3T3 cell lines.
All 62 of the BALB/c mice, that were less than 48 hr
old when infected with R7 and MoMuLV-TB produced by
R7N8 cells superinfected with MoMuLV-TB, developed
sarcomas in subcutaneous tissues, spleens, and mesen-FIG. 1. Northern analysis of SV7 and uncloned R7 RNA. Total RNAs
tery surrounding various organs. Vessels supplying these(10 mg each) from cell lines SVN4 and R7NM infected with SV7 (lane
1) and uncloned R7 and MoMuLV-TB (lane 2), respectively, were frac- sarcomas were lined by proliferative and enlarged endo-
tionated by electrophoresis in a denaturing 1.5% formaldehyde gel, thelial cells with eccentric nuclei. More interestingly, R7
transferred to a nylon membrane, and hybridized to a 32P-labeled mos- also induced brain lesions in about 70% of the R7- andspecific probe (a 909-bp SV7 BglII3669 –HindIII4578 fragment). The sizes
MoMuLV-TB-infected mice examined. Light microscopicof the RNAs were calculated from a set of unlabeled marker RNAs
(lane M). examination of thin sections of the brain revealed that
about 15% of the lesions were unenclosed blood pools of
varying sizes containing red blood cells and inflammatoryprovided us with a restriction map of pR7.1, as shown in
cells that spread into surrounding brain tissues. The re-Fig. 2. Based on the structure of the SV7 genome (Yuen
mainder of the brain lesions had tumor cells. These le-et al., 1991), the complete R7 linear genome was con-
sions ranged from a few enlarged vascular endothelialstructed by first ligating the approximately 0.9-kb SacI –
cells intermixed with blood cells to large circumscribedXhoI fragment of the 5* end of the R7 genome in pR7.1
lesions consisting of well-developed tangled masses ofto the 3* end of the 2.7-kb SacI–SacI fragment and then
vessels surrounded by blood pools. These hemangioen-ligating the approximately 0.7-kb HindIII– SacI fragment
dotheliomas were surrounded by activated astrocytesof the 3* end of R7 to the 5* end of the 2.7-kb SacI–SacI
that stained intensely with antibodies against glial fibril-pR7.1 fragment (Fig. 2). The complete linear R7 genome
lary acidic protein. Details of these studies are reportedin Sp72 was named pR7. Restriction enzyme analysis of
elsewhere (Yuen and Kwak, submitted).pR7 showed that the structure of R7 is consistent with
Since R7 had acquired the ability to induce brain le-that of pR7.1 (data not shown).
sions and the genetics of the mos-containing viruses hadTo verify that the linear R7 proviral DNA is infectious,
been shown to dictate pathogenicity, to better character-linearized pR7 DNA and pSV2Neo DNA in a 20:1 ratio
ize the organization of the R7 genome, the complete R7were electroporated into NIH/3T3 cells. A stably trans-
proviral DNA was sequenced. Endonuclease-restrictedformed G418-resistant single-cell clone, R7N8, was es-
fragments of pR7.1 were subcloned into the plasmidtablished. The integrity of the R7 genome was verified
pSP72. Since pR7.1 did not contain the ends of the LTRs,by Southern and Northern blot analyses (data not shown).
To determine if clone R7N8 produced infectious R7 the LTRs of pR7 were also amplified by PCR. The pR7.1
FIG. 2. Schematics showing the restriction maps of the molecularly cloned R7 provirus and the reconstructed linear R7 provirus. Restriction
enzymes used were as follows: A, AatII; E, EagI; C, ClaI; H, HindIII; K, KpnI; P, PstI; Sc, SacI; Sm, SmaI; X, XhoI. LTR, long terminal repeat.
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subclones and the PCR-amplified products were sent for R7 genome, the sequence spanning these repeats was
deleted, but in contrast to deletion I, both repeats wereautomated sequencing at the sequencing facility at the
M. D. Anderson Cancer Center in Houston, Texas. retained except for 2 bp (GC) at the 3* end of the 5* end
repeat.The complete R7 genomic DNA sequence is shown in
Fig. 3. Since the SV7 sequence has not been reported, The R7 genome ranks as the shortest genome among
the spontaneously generated MoMuSV variants. Furtherthe R7 DNA sequence was compared with that of Mo-
MuSV124 (Van Beveren et al., 1981). analysis of the R7 genome showed that deletion of 203
bp of the N-terminus of the env–mos gene resulted inThe R7 genome consisted of 3401 bp. It was generated
by a combination of insertion and deletion of the Mo- the loss of the first 2 Met codons of the env–mos coding
sequence. In addition, the reading frame of p15 begin-MuSV124 genome as detailed below.
First, in each R7 LTR, 76 bp of the two tandem direct ning at the first Met codon is in-frame with the 263 bp
of the p30 coding sequence, the 7-bp insertion, and therepeats (DRs) were duplicated and inserted between the
first DR and the second DR. Examination of the DR se- truncated mos coding sequence (Fig. 4).
The occurrence of short repeats of 4–9 bp at intras-quences showed that the first 16 bp of the new DR were
identical to the first 16 bp of the second MoMuSV124 trand deletion junctions and between viral and cellular
sequences has been observed between MoMuLV andDR. The origin of these 16 bp was readily ascertained
because the first 16 bp of the second MoMuSV124 DR c-mos, MoMuSV124, ts110, HT1, m1, or Gazdar-MuSV
(Van Beveren et al., 1981; Donoghue and Hunter, 1983;were not identical to those of the first DR. In the first DR,
bp 9–11, 15, and 16 were deleted and nucleotide 14 was Stacey et al., 1984; Huai et al., 1992), between feline
leukemia virus and c-sis (Josephs et al., 1983), and be-changed from G to A. The first 16 bp of the new 76-bp
DR were identical to those of the second MoMuSV124 tween Rous sarcoma virus and c-src (Hevezi and Goff,
1991). This pattern of short repeat sequences of 4–9 bpDR. The remaining 60 bp of the new DR were identical
to the homologous sequence of the first MoMuSV124 at intrastrand deletion junctions and between viral and
cellular sequences appears to be common among retro-DR. The sequence of the second MoMuV124 DR that is
homologous to the 60 bp of the first MoMuSV124 DR had viruses and applies to the SV7 deletions observed in R7.
How deletion occurs in general and in the generationonly 58 bp, with 2 bp being deleted at its 5* end. In
addition, nucleotides G and A in positions 25 and 42, of R7 could be considered a modified recombination
event in the recombination model proposed by Coffinrespectively, in the 60-bp sequence of the first DR were
replaced by A and G in the second DR. (1979). The short homologous sequences observed at
deletion junctions and the partial or complete loss of oneSecond, in comparison with the MoMuSV124 genome,
2591 bp of the MoMuSV124 gag–pol–env–mos se- of the repeats in R7 suggest that the newly synthesized
3* end repeat somehow aligned with the 5* homologousquence were deleted in the R7 genome. Deletion I ex-
tended from bp 1218 to bp 1817 (inclusive), and deletion sequence of either the same strand or its copackaged
partner, after which negative-strand synthesis continued.II extended from bp 2081 to bp 4071 (inclusive) of the
MoMuSV124 DNA sequence. These 2591 deleted base In SV7 deletion I, synthesis resumed from the nucleotide
next to the 5* repeat, whereas in deletion II, synthesispairs included 217 bp of the 3* end of the coding se-
quence of p15, all the coding sequence of p12, all the resumed from the third nucleotide of the 5-bp 5* repeat.
A second process that contributed to the generationcoding sequence of p30 except for the central 263 bp,
all the coding sequence of p10, pol, and env, and 183 of the R7 genome was the insertion of a 7-bp sequence
of uncertain origin at the 5* end of the truncated mosbp of the 5* end of the mos gene.
Third, there was also insertion of a 7-bp (TCCCTGC) gene. As shown in Fig. 3, the inserted 7-bp sequence is
flanked by a 2-bp repeat (CT). Indirect repeats of 4–6sequence between MoMuSV124 bp 4077 and bp 4078
at the gag–mos junction of R7. bp of cellular DNA flanking integrated MoMuSV proviral
DNAs have been observed (Dhar et al., 1980; ShimotohnoAnalysis of the sequence at the deletion I junction of
the R7 and MoMuSV124 genomes showed that, in dele- et al., 1980; Hughes et al., 1981; Van Beveren et al.,
1981). Unlike the known cell–viral junctions, the insertedtion I, a 12-bp sequence (CCTCATCACCCA) extending
from bp 1218 to 1229 was repeated in bp 1818–1829 in sequence is flanked by 2-bp direct repeats, and the insert
is not terminated by 5*TG. . .CA3*.the MoMuSV124 gag gene. In the R7 genome base pairs
spanning these two repeats were deleted, and only one A third process that contributed to the generation of
the R7 genome was the duplication of 76 bp from thecopy of the repeated sequence was retained at the dele-
tion junction. two tandem DRs in each SV7 LTR. The number of repeats
in retrovirus enhancers ranged from one to four. In mostSimilarly, in deletion II, bp 2081–4071 (inclusive) of
MoMuSV124 were deleted. This sequence began in the cases, the repeats were imperfect copies. Rearrange-
ments in the DRs of viral enhancers appear commonp30 coding sequence and extended into the mos coding
sequence. Five base pairs, GAAGC (2078–2082 inclu- in viruses recovered from MoMuLV-induced tumors and
SL3- and SAA-induced tumors (Brightman et al., 1993;sive), were repeated in bp 4072–4076 (inclusive). In the
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FIG. 3. The complete R7 DNA sequence and comparison of the R7 direct repeats (DR), deletions I and II, and 7-nucleotide insertion (boldface
lettering) with the sequence of MoMuSV124 (Van Beveren et al., 1981). The 76-nucleotide R7 DR 2 is duplicated from the underlined nucleotides
of MoMuSV124 DR 1 and 2, the 2 nucleotides that differ in MoMuSV124 DR1 and 2 are in boldface, and nucleotides absent in the DRs are indicated
by an x or a space. The beginning and end of p15 and p30 are indicated. m1 mos indicates the beginning of MoMuSV124 mos, m3 mos represents
the third Met codon of MoMuSV124 and R7, and the underlined TGA represents the stop codon of R7 and MoMuSV124 Mos. Dashes indicate
nucleotides deleted from the R7 sequence; dots indicate MoMuSV124 nucleotides that are identical to those of R7; //, truncated sequence; sequence
in lowercase letters indicates direct repeats at deletion junctions; numbers below sequence indicate first and last nucleotides of the MoMuSV124
sequence deleted in R7; 7 nucleotides in boldface indicate sequence inserted into the R7 genome; the 6 nucleotides in italics at the beginning of
the 7-nucleotide insertion represent an additional R7 HindIII site. The R7 sequence data have been deposited with the GenBank Data Library under
Accession No. AF011892.
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FIG. 4. (A). Computer-generated open reading frames (RF 1–6) deduced from the R7 DNA sequence. (B) The amino acid sequence deduced from
RF 2 of the R7 DNA sequence. The p15, p30, and Mos amino acid residues are indicated. ‘‘Insert’’ indicates the altered amino acid residues due
to deletion and insertion of nucleotides.
Morrison et al., 1995). However, the composition of the strands A and B as follows (Fig. 5): Reverse transcriptase
synthesized dr 3 using DR 2 of strand A as template.extra R7 DR provided additional insight into the mecha-
nism involved in the generation of DRs. Reverse transcriptase then switched to strand B, dr 3
aligned with DR 2 of strand B, and reverse transcriptaseDuplication of the tandem repeats of the LTR has been
postulated to occur by misalignment of repeat sequences synthesized the first 60 bp of dr 2 using DR 1 as template.
Reverse transcriptase then switched a second time backduring reverse transcription (Morrison et al., 1995). In this
model, after the synthesis of the negative strand of the to strand A, dr 2 aligned with the 60 bp of DR 2 of strand
A, and reverse transcriptase synthesized the remainingfirst of two repeats, the synthesized strand may align
with the first repeat of the second copackaged strand 16 bp of dr 2 using DR 2 as template, before continuing
the synthesis of dr 1 using DR 1 as template.and reverse transcriptase may reverse transcribe both
repeats. The result is three repeats with the middle re- The duplication, deletions, and insertion that occurred
in the SV7 genome resulted in the R7 genome with sev-peat being identical to the first repeat transcribed. A more
complex mechanism must be postulated, however, to eral important structural modifications including (i) incor-
poration of an additional repeat in the enhancer, (ii) trun-explain how 76 bp from the two tandem SV7 DRs were
duplicated to generate the third R7 DR, because we have cation of most of the MoMuLV-derived gag–pol–env se-
quence, (iii) truncation of the N-terminus of the mos gene,clearly demonstrated that 16 of the 76 bp were duplicated
from the SV7 DR 2 while the remaining 60 bp were dupli- and (iv) generation of a p15–p30–mos fusion protein that
is most likely myristylated. One or more of these struc-cated from the SV7 DR 1 (Fig. 3). These findings suggest
that reverse transcriptase switched templates twice be- tural changes altered the replication, transforming activ-
ity, and disease potential of R7.tween the copackaged homodimeric genomic RNA
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and Murphy, E. C. J. (1992). Moloney murine sarcoma virus
MuSVts110 DNA: Cloning, nucleotide sequence, and gene expres-
sion. J. Virol. 66, 5329–5337.
Hughes, S. H., Mutschler, A., Bishop, J. M., and Varmus, H. E. (1981). A
Rous sarcoma virus provirus is flanked by short direct repeats of a
cellular DNA sequence present in only one copy prior to integration.
Proc. Natl. Acad. Sci. USA 78, 4299–4303.
Josephs, S. F., Favera, R. D., Gelmann, E. P., Gallo, R. C., and Wong-
Staal, F. (1983). 5* Viral and human cellular sequences corresponding
to the transforming gene of simian sarcoma virus. Science 219, 503–
505.
Mann, R., Mulligan, R. C., and Baltimore, D. (1983). Construction of a
retrovirus packaging mutant and its use to produce helper-free defec-
tive retrovirus. Cell 33, 153–159.
FIG. 5. A model postulated for duplication of the extra R7 76-bp direct Morrison, H. L., Soni, B., and Lenz, J. (1995). Long terminal repeat en-
repeat. Strands A and B represent the homodimeric SV7 RNA genomes. hancer core sequences in proviruses adjacent to c-myc in T-cell
DR 1 and DR 2 represent the direct repeats of the SV7 LTR. dr 1–3 lymphomas induced by a murine retrovirus. J. Virol. 69, 446–455.
represent the newly synthesized R7 negative-strand DNA. Verticle bars Reddy, E. P., Smith, M. J., and Aaronson, S. A. (1981). Complete nucleo-
divide the DRs into the 16- and 60-bp segments. Closed rectangles tide sequence and organization of the Moloney murine sarcoma virus
represent the 2 nucleotides of the SV7 DR 1 that are missing in DR 2. genome. Science 214, 445–450.
The model is explained further in the text. Shimotohno, K., Mizutani, S., and Temin, H. M. (1980). Sequence of
retrovirus provirus resembles that of bacterial transposable ele-
ments. Nature 285, 550–554.
R7 induces brain hemangioendotheliomas in addition Stacey, A., Arbuthnott, C., Kollek, R., Coggins, L., and Ostertag, W.
(1984). Comparison of myeloproliferative sarcoma virus with Moloneyto sarcomas in subcutaneous tissues, spleens, and mes-
murine sarcoma virus variants by nucleotide sequencing and hetero-entery. This is in contrast to SV7 which induces tumors
duplex analysis. J. Virol. 50, 725–732.
only in the subcutaneous tissues, spleens, and mesen- Stocking, C., Kollek, R., Bergholz, U., and Ostertag, W. (1986). Point
tery (Yuen et al., 1991). It remains to be determined mutations in the U3 region of the long terminal repeat of Moloney
murine leukemia virus determine disease specificity of the myelopro-whether R7’s ability to induce brain lesions is caused by
liferative sarcoma virus. Virology 153, 145–149.the presence of an additional enhancer, deletion of most
Stoica, G., Hoffman, J., and Yuen, P. H. (1990). Moloney murine sarcomaof the MoMuLV-derived sequences, deletion of the N-
virus 349 induces Kaposi’s sarcomalike lesions in BALB/c mice. Am.
terminus of mos, synthesis of a myristylated p15–p30 – J. Pathol. 136, 933–947.
Mos fusion protein, or all of the above. Previous studies Szurek, P. F., Yuen, P. H., Jerzy, R., and Wong, P. K. (1988). Identification
of point mutations in the envelope gene of Moloney murine leukemiahave demonstrated the importance of each of these
virus TB temperature-sensitive paralytogenic mutant ts1: Molecularstructural changes in retrovirus-induced pathogenesis.
determinants for neurovirulence. J. Virol. 62, 357–360.
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